Roman Yelensky - Jan 19, 2021 Form 4/A - Amendment Insider Report for Gritstone bio, Inc. (GRTS)

Role
Executive Vice President and Chief Technology Officer
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Roman Yelensky
Stock symbol
GRTS
Transactions as of
Jan 19, 2021
Transactions value $
-$221,029
Form type
4/A - Amendment
Date filed
11/19/2021, 05:06 PM
Date Of Original Report
Jan 21, 2021
Previous filing
Nov 19, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Sale -$221K -10K -5.86% $22.10* 161K Jan 19, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $22.00 to $22.40 per share. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2 Includes 27,400 RSUs which are subject to vesting.

Remarks:

Executive Vice President and Chief Technology Officer